Robert Valdes, Carey ’06
Biotech Resources Group
Robert (Bob) Valdes has over 25 years of biotechnology experience. Previously, he was the cofounder of Alliancebio, LLC serving clients in the US, EU, and east Asia. Prior to this start-up, Bob served as the Director of Large-Scale Manufacturing at Human Genome Sciences (acquired by GSK) where he oversaw the manufacture of Human Genome’s first commercial product Benlysta®, the first lupus drug to make it through US regulators in more than half a century. Prior to his 12-year tenure at Human Genome Sciences, he was employed by Lonza Biologics (US/UK) from 1994 to 2000 in various positions in biologics manufacturing, design, and engineering.
As a strong community citizen, Bob founded and operated RRMS Inc. for 12 years. RRMS was a nonprofit (501c3) benefitting the Multiple Sclerosis community in over 20 states.
Bob holds a MS degree from the University of Massachusetts and a MBA from the Johns Hopkins Carey Business School. He received his BA in microbiology from the University of New Hampshire.